Ami Organics Limited

2,021.95

INR
+47.60(+2.41%)
As of November 14, 2024 10:00:00 AM

About Ami Organics Limited

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Ami Organics Limited exports its products. The company was founded in 2004 and is based in Surat, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
10.61x
Operating MarginLast 12 months
13.21
+-16.2% quarterly YoY
Market Cap
7856.35 CrINR
Employees
676
CEO
NA
Website

Ami Organics Limited

2,021.95

INR
+47.60(+2.41%)
As of November 14, 2024 10:00:00 AM

About Ami Organics Limited

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Ami Organics Limited exports its products. The company was founded in 2004 and is based in Surat, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
10.61x
Operating MarginLast 12 months
13.21
+-16.2% quarterly YoY
Market Cap
7856.35 CrINR
Employees
676
CEO
NA
Website